Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9151
Sight Sciences
SGHT
$456M
| $321K | ﹤0.01% |
36,732
+36,634
| +37,382% | +$407K |
|
9152
PUT
Perdoceo Education
PRDO
$2.04B
| $321K | ﹤0.01% |
23,900
+6,600
| +38% | +$92.4K |
|
|
AAN
9153
CALL
DELISTED
The Aaron's Company Inc
AAN
| $321K | ﹤0.01% |
33,200
+8,300
| +33% | +$107K |
|
9154
AllianzIM U.S. Equity Buffer20 Nov ETF
NVBW
$96.2M
| $321K | ﹤0.01% |
12,150
-418
| -3% | -$10.8K |
|
9155
PUT
Douglas Emmett
DEI
$1.94B
| $321K | ﹤0.01% |
26,000
+3,200
| +14% | +$46.4K |
|
|
BSCN
9156
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
| $320K | ﹤0.01% |
15,199
-15,549
| -51% | -$327K |
|
9157
AllianzIM U.S. Equity Buffer20 Mar ETF
MARW
$87.7M
| $320K | ﹤0.01% |
+12,566
| New | +$315K |
|
9158
CALL
Hancock Whitney
HWC
$6.28B
| $320K | ﹤0.01% |
8,800
+5,300
| +151% | +$247K |
|
9159
Lifestance Health
LFST
$4.72B
| $320K | ﹤0.01% |
43,111
+42,761
| +12,217% | +$237K |
|
9160
First Trust Japan AlphaDEX Fund
FJP
$259M
| $320K | ﹤0.01% |
7,065
-141,598
| -95% | -$6.22M |
|
9161
CALL
RLJ Lodging Trust
RLJ
$1.71B
| $320K | ﹤0.01% |
30,200
+27,600
| +1,062% | +$310K |
|
|
ME
9162
PUT
DELISTED
23andMe Holding Co
ME
| $320K | ﹤0.01% |
7,020
-2,920
| -29% | -$141K |
|
9163
PUT
Theravance Biopharma
TBPH
$880M
| $320K | ﹤0.01% |
29,500
-3,700
| -11% | -$39.1K |
|
9164
CALL
Cohen & Steers
CNS
$4.24B
| $320K | ﹤0.01% |
5,000
+3,100
| +163% | +$216K |
|
9165
Biomea Fusion
BMEA
$97.1M
| $320K | ﹤0.01% |
10,309
-13,521
| -57% | -$168K |
|
9166
CALL
Biohaven
BHVN
$2.1B
| $320K | ﹤0.01% |
23,400
-11,200
| -32% | -$178K |
|
9167
CALL
Gentex
GNTX
$5.03B
| $320K | ﹤0.01% |
11,400
+200
| +2% | +$5.63K |
|
9168
PUT
Procore
PCOR
$9.13B
| $319K | ﹤0.01% |
5,100
-9,500
| -65% | -$555K |
|
|
SVM
9169
PUT
Silvercorp Metals
SVM
$2.55B
| $319K | ﹤0.01% |
83,600
+2,600
| +3% | +$8.56K |
|
9170
CALL
Immersion
IMMR
$248M
| $319K | ﹤0.01% |
35,700
-1,800
| -5% | -$13.6K |
|
9171
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.1M
| $318K | ﹤0.01% |
8,000
-4,500
| -36% | -$190K |
|
9172
Matthews China Active ETF
MCH
$22.9M
| $318K | ﹤0.01% |
+13,220
| New | +$337K |
|
9173
Novanta
NOVT
$6.07B
| $318K | ﹤0.01% |
2,001
-1,358
| -40% | -$209K |
|
9174
FT Vest US Equity Enhance & Moderate Buffer ETF June
XJUN
$139M
| $318K | ﹤0.01% |
9,903
+3,117
| +46% | +$98.2K |
|
9175
FT Vest US Equity Buffer ETF November
FNOV
$1.24B
| $318K | ﹤0.01% |
+8,465
| New | +$311K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.